“Any extension of the pause will invariably result in the fact that the most vulnerable individuals in the United States who are prime candidates for the Janssen/Johnson and Johnson vaccine will remain vulnerable. The most at risk will remain at risk, and those who would benefit immediately from vaccination who will remain unvaccinated for an unknown period of time,” said Dr. Nirav Shah, director of the Maine Center for Disease Control and Prevention.
Send an email
